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Abstract: Almonds provide a satiating, healthy source of fat and fiber. The postprandial metabolic
and satiety response to 2 ounces of nuts or dairy was assessed in 18 overweight/obese women during
late pregnancy. Serum glucose, triglycerides, insulin, c-peptide, leptin, ghrelin, and lipoprotein
particles were measured prior to and during a 5-h postprandial period following the consumption
of an isocaloric breakfast meal with equivalent amounts of fat from either nuts or dairy on two
separate mornings. Satiety was assessed by visual analogue scale (VAS) questionnaires and ad
libitum food intake at the end of the study. At 33 weeks gestation, the women had gained an
average of 7.0 ± 4.4 kg during gestation. Body fat averaged 41.9 ± 5.5% and hemoglobin A1c levels
were elevated, (7.2 ± 0.6%). Fasting glucose levels were normal, but hyperinsulinemia was evident.
The two test meals did not affect the postprandial metabolic response, but glucose, triglyceride,
and ghrelin concentrations changed with time during the postprandial period (p < 0.001, p = 0.0008,
p = 0.006). Satiety measures did not differ between the two test meals. Consuming an isocaloric
breakfast meal with equivalent amounts of fat from nuts or dairy did not alter postprandial levels of
blood lipids, glucose, hormones, or measures of satiety in overweight/obese, pregnant women.
Keywords: metabolism; overweight; pregnancy; dairy; nuts
1. Introduction
Half of all American women of childbearing age are overweight, and one-third are obese [1].
The prevalence of metabolic disorders during and after pregnancy has increased concurrently with
the rise in maternal obesity [2–4]. Metabolic abnormalities (i.e., hyperglycemia) during pregnancy
may predispose the offspring to subsequent obesity and chronic diseases [5–7]. Excessive weight gain
during pregnancy by overweight and obese women creates a higher risk of prenatal complications,
retention of excess body fat postpartum, and the development of metabolic diseases in the offspring
later in life [8–10].
Overweight/obese, pregnant women are at increased risk for developing gestational diabetes
and dyslipidemia [10]. The maternal insulin resistance that normally develops during pregnancy
increases the placental uptake of glucose and lipid and the transfer of these substrates to the fetus, thus
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supporting fetal growth. Maternal obesity enhances the insulin resistance present during pregnancy
and increases the risk of hyperglycemia and hypertriglyceridemia in late pregnancy [11]. Unhealthy
eating patterns and suboptimal levels of physical activity contribute to excessive weight gain during
pregnancy [11,12]. Thus, to improve pregnancy outcomes and the long-term health of the mother
and child, clinical programs designed to control weight gain and reduce metabolic disorders are
needed. Although dietary interventions are used routinely to reduce metabolic disease in non-pregnant
obese individuals, no national or international dietary standards have been established for obese,
pregnant women unless they develop Gestational Diabetes Mellitus (GDM) [13]. It is important,
therefore, to identify healthy food sources that reduce the risk of glucose intolerance and dyslipidemia
while increasing satiety. These foods could then be part of a recommended dietary pattern for
overweight/obese pregnant women to support a healthy metabolism throughout pregnancy.
The consumption of unsaturated fatty acid-rich lipid food sources has been shown to improve
cardiometabolic health. Almonds, which are high in monounsaturated fatty acids and fiber, provide
flavor and satiety to the diet. Also, their net metabolizable energy is low, which helps manage
body weight [14,15]. In non-pregnant adults, almond consumption reduced oxidative stress and
inflammation and promoted vascular health and glycemic control [16–18]. The purpose of this
study, therefore, was to compare the effects of two isocaloric fat sources, dairy (cream cheese) or
nuts (almonds), on postprandial metabolism and satiety in overweight/obese pregnant women.
Since almonds provide more unsaturated fat than cream cheese, we hypothesized that the postprandial
metabolic response to almonds would be more favorable than the response to higher saturated fat,
cream cheese.
2. Materials and Methods
2.1. Experimental Design
Eighteen overweight/obese, pregnant women in the third trimester were recruited to participate
in a cross-over, randomized controlled trial examining the metabolic response to consuming equivalent
amounts of dairy (cream cheese) or nuts (almonds) in two standardized, isocaloric breakfast meals
matched for carbohydrate, protein, and fat levels. Clinical trial registration number NCT01919476. Each
participant consumed both test meals on separate days within 3–7 days in random order (computer
generated sequence). On the test days, the participants came to the Cholesterol Research Center
(CRC) in Berkeley, CA, to complete the six-hour study. After a fasting blood sample was collected,
the women consumed one of the test meals and postprandial blood samples were collected at 30 min,
1, 2, 3, 4, and 5 h to measure hormones and metabolic biomarkers of glucose and lipid metabolism.
After completing the 5-h postprandial study, the women were offered an ad libitum lunch and the
amount of food consumed was weighed and recorded.
2.2. Study Participants
Pregnant women were recruited from prenatal practices in Oakland/Berkeley, CA, to participate
in the study. Inclusion criteria included being between 30–36 weeks of pregnancy, a pre-pregnancy BMI
between 25–40 kg/m2, and a willingness to come to the CRC for two six-hour studies. Exclusion criteria
included a diagnosis of gestational diabetes, diabetes pre-pregnancy, or other metabolic disorders
(i.e., renal, thyroid, or bone disorders). The UCSF Benioff Children’s Hospital, Oakland, institutional
review board reviewed and approved the study. All of the women signed a consent form after
thoroughly reviewing the study details with research personnel and after discussing the study with
family members and friends. The participants received a stipend of $300 for completing both test days.
2.3. Study Day Procedures
On the test days, participants arrived at the CRC between 7:30 AM and 8:30 AM after a ten-hour
overnight fast. The women were told to drink at least eight ounces of water prior to coming to the
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CRC. Upon arrival, the women relaxed in a reclining blood-draw chair and an indwelling catheter was
placed in the antecubital vein. After collecting the fasting blood sample, the women consumed one
of the two test meals within 20 min. Subsequent blood samples were drawn through the indwelling
catheter at 30 min, 1, 2, 3, 4, and 5 h. Prior to each blood draw, participants completed a visual analogue
satiety (VAS) questionnaire. At the end of the postprandial study, participants were offered a buffet
lunch with individual weighed portions for each food item. Total food consumption was determined
from the difference between the weighed amounts of food offered and any uneaten food.
2.4. Test Meals
Since carbohydrate and lipid postprandial metabolism may be influenced by food intake during
the past six to eight hours [19], a standard evening meal was provided prior to each study day.
The 600-kcal, standard dinner consisted of a frozen ovo-lacto vegetarian entrée along with fruit and a
non-caloric beverage.
The characteristics of the two standardized breakfast test meals are shown in Table 1. Both meals
contained 240 g of apple juice and a 65-g bagel. For the almond (nuts) test meal, 60 g (approximately two
ounces) of blended almonds was served. For the cream cheese (dairy) test meal, 86 g (approximately
three ounces) plus a small amount of supplemental Beneprotein (Nestle Healthcare Nutrition,
Minnetonka, MN, USA) and Polycose (Abbott Nutrition, Abbott Park, IL, USA) powders to equalize
the amount of carbohydrate and protein in the two meals was served. The nut meal was lower in
saturated fat and higher in total fiber. Palatability and acceptability of both test meals was previously
tested in non-pregnant volunteers [20].
Table 1. Test Meal Macronutrient Characteristics.
Test Meal Meal Contents TotalCalories
Total
Fat
(% Energy)
Saturated
Fat
(% Energy)
Total
Protein
(% Energy)
Total Carb
(% Energy)
Total
Fiber
Dairy
(Cream
Cheese)
65 g bagel
240 g apple juice
86 g cream cheese
9 g Polycose powder
8 g Beneprotein powder
665 kcal 31 g(42%)
18 g
(24%)
19 g
(12%)
77 g
(46%) 2 g
Nut
(Almonds)
65 g bagel
240 g apple juice
56.7 g almonds
665 kcal 31 g(42%)
3 g
(4%)
19 g
(12%)
77 g
(46%) 9 g
2.5. Body Anthropometrics and Composition
All measurements of body anthropometrics and composition were done at the second study visit.
Body weight was measured in undergarments to the nearest 0.1 kg using a standing digital scale
(BWB-800, Tanita, Arlington Heights, IL, USA). Height was measured to the nearest 0.1 cm by using a
wall-mounted stadiometer (Perspectives Enterprises, Portage, MI, USA). All measures were done in
duplicate and averaged. Maternal BMI was calculated as: weight (kg)/height (m)2.
Body density was estimated using the BODPOD body composition system (Life Measurement
Instruments, Concord, CA, USA), which estimates body volume from the amount of air displaced by a
subject’s body when seated in a fiberglass chamber [21]. Body density was measured two hours after
the participant had consumed the test meal. Participants wore tight-fitting clothing, a swim cap, nose
clip without any jewelry or accessories for the measurement. After voiding, the participants entered
the BODPOD chamber, and body volume was measured twice during a five-minute time period and
averaged. Thoracic gas volume (TGV) was also measured by having the participant blow into an
attached breathing tube while in the chamber. If a valid TGV measurement could not be made, an
equation for predicting TGV was used [22]. Body density was calculated from the ratio of body mass
(weight) to body volume. A three-compartment model was used to estimate percent body fat and
body fat-free mass [23] and the methods are detailed in our previous study [24].
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2.6. Blood Sampling, Aliquoting, and Analysis
Blood samples were collected from the antecubital vein of recumbent subjects in the fasting state
and at 30 min, 1, 2, 3, 4, and 5 h postprandial. Blood samples were separated for serum or plasma via
centrifugation and stored at −80 ◦C until analysis. The collection times and methods for analysis are
shown for each endpoint in Table 2.
Table 2. Blood Analyses.
Parameter Sample CollectionTimes Points (Hours) Analysis Method
Sample Collected (+
Additives If Any)
Glucose 0, 0.5, 1, 2, 3, 4, 5 Polychemical Clinical Analyzer, MedTest DX(Cortlandt Manor, NY) Plasma
Triglyceride 0, 0.5, 1, 2, 3, 4, 5 Polychemical Clinical Analyzer, MedTest DX(Cortlandt Manor, NY) Plasma
Ghrelin 0, 0.5, 1, 2, 3, 4, 5
Multi-array Electrochemiluminescence (Human
Ghrelin Prototype Assay),
Meso Scale Discovery (Rockville, MD)
Plasma + aprotinin
inhibitor
Insulin 0, 0.5, 1, 2, 3, 4, 5
Multi-array Electrochemiluminescence (Human
Active GLP-1, Insulin, Glucagon, Leptin Assay Kit),
Meso Scale Discovery (Rockville, MD)
Plasma + DPP-IV
inhibitor + aprotinin
inhibitor
Hemoglobin A1c 0 Enzymatic, Diazyme (Poway, CA) Whole blood
Leptin 0, 0.5, 1, 2, 3, 4, 5
Multi-array Electrochemiluminescence (Human
Active GLP-1, Insulin, Glucagon, Leptin Assay Kit),
Meso Scale Discovery (Rockville, MD)
Plasma + DPP-IV
inhibitor + aprotinin
inhibitor
C-peptide 0, 1, 3, 5
Multi-array Electrochemiluminescence (Human
C-Peptide Prototype Assay),
Meso Scale Discovery (Rockville, MD)
Plasma
Apolipoprotein B 0, 1, 3, 5
Immunoturbidimetric assay [25,26] (Kamiya
Biomedical Company, Seattle, Washington), Liasys
330 automated chemistry analyzer
Serum
High Molecular
Weight
Adiponectin
0
Multi-array Electrochemiluminescence (Human
Adiponectin Assay Kit),
Meso Scale Discovery (Rockville, MD)
Plasma
High-sensitivity
C-Reactive Protein 0
Multi-array Electrochemiluminescence (C-Reactive
Protein Assay), MSD (Rockville, MD) Plasma
Total-cholesterol 0
Enzymatic end-point measurement (AMS
Diagnostics, Brookfield, Connecticut), Liasys
330 automated chemistry analyzer
Plasma
Low Density
Lipoprotein-cholesterol 0
Calculated by subtraction of estimated Very Low
Density Lipoprotein and measured High Density
Lipoprotein cholesterol from the measured total
cholesterol and triglyceride in plasma
Plasma
High Density
Lipoprotein-cholesterol 0
Enzymatic end-point measurement (AMS
Diagnostics, Brookfield, Connecticut), Liasys
330 automated chemistry analyzer
Plasma
Lipid-particle size 0
Ion mobility (IM) analysis, electrospray utilized to
create an aerosol of particles that pass through a
differential mobility analyzer (DMA) coupled to a
particle counter [27]
Plasma
2.7. Satiety Assessment
Immediately before each blood sampling, the participants were given a VAS satiety
questionnaire [16]. Satiety was also assessed by measuring the ad libitum food intake from a buffet of
pre-weighed lunch items. The same buffet menu was fed on both study days.
2.8. Statistical Analysis
Power calculation: The glycemic response to the test meals was the primary outcome of
interest. In a previous study of seven individuals with type 2 diabetes mellitus [28], the postprandial
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glucose area under the curve averaged 429 ± 75 mmol/min/L following the control meal and
299 ± 63 mmol/min/L following the almond meal, about a 30% reduction (p < 0.04). Since the
women in our study did not have diabetes, we predicted that the glycemic response difference between
the dairy and nut meals would be smaller, about 80 mmol/min/L rather than 130 mmol/min/L.
A sample size of 11 women was needed to detect a difference of 80 mmol/min/L using a two-tailed
test when α = 0.05 and Power = 0.80.
Data was transferred to SAS data sets and analyzed using SAS software version 9.3 (SAS
Institute, Inc. 2010, Cary, NC, USA). The value of p = 0.05 was used as the cut-off level for statistical
significance [29,30]. Prior to any analyses, data were checked for outliers. Once the data set was
finalized, a descriptive analysis for each time point in each diet group was done to examine means,
proportions, measures of variability and correlations.
Both cross-sectional and longitudinal analyses of the data were performed using generalized linear
mixed-effects models (GLMM) to test the hypothesis that the metabolic response to the control meal
(dairy, cream cheese) differed from the intervention meal (nuts, almonds) over time. The longitudinal
models accounted for any within-subject correlations over time and with the two diets. A series of
models were run to test the hypothesis that a breakfast meal with nuts differed from dairy in appetite
or metabolites of glucose or lipid metabolism. The association between fasting and postprandial lipid
profiles was also determined.
For each fasting state and postprandial biomarker outcome, we first screened for any sequence
effects (order of test meal received) while controlling for diet, time postprandial and study visit 1 or 2
in the models. Since no meal sequence effects were observed, sequence was excluded from each model
and data from both study visits were used. For data measured only during the fasting state (HMW
Adiponectin, hs-CRP, Total-Cholesterol, LDL-cholesterol, HDL-cholesterol, lipoprotein particle size,
HgbA1c), the models included diet and study visit. For the postprandial data, each model controlled
for baseline values of the biomarker assessed. Furthermore, Tukey’s method of multiple comparisons
was used to assess any differences between the dairy and nut meals at each time point. A separate
model was used to explore the relationship between potential covariates (lipid profile, pre-pregnancy
weight, pre-pregnancy BMI, gestational age, gestational weight gain, and measured body fat) with
each of the measured outcomes at all time points in order to determine which covariates could be
adjusted for in the model.
For the VAS satiety questionnaire responses, analysis of variance models (ANOVA) and the Wilcoxon
signed rank test were used to determine differences in response at each time point. The Wilcoxon
signed rank test was also used to determine the breakfast test meal effect on energy consumption from
the lunch meal.
3. Results
3.1. Participant Characteristics
Eighteen (two Asian and sixteen Latina) pregnant women aged 28 ± 5.9 years participated in
the study. Their self-reported pre-pregnancy weight averaged 77.6 ± 16.4 kg with a corresponding
mean BMI of 31 ± 5.9 kg/m2. Estimated gestational weight gain at the first study visit (i.e., 32.6 weeks
gestation) averaged 6.3 ± 4.7 kg (Table 3). An additional 1.3 ± 4.0 kg was gained by the second study
visit approximately 1 week later bringing their total weight gain to 7.7 ± 4.9 kg at 33 weeks gestation.
Total body fat, measured at the second visit, was 41.9 ± 5.5%. The average hemoglobin A1c level,
7.2 ± 0.6%, was slightly elevated compared to what is expected in pregnancy (6–7% [31]), suggesting
an underlying insulin resistance. Fasting serum adiponectin levels on visit 1 were also on the lower
end (7.3 µg/mL) of the normal range (4–22 µg/mL, for women with BMI >30), which is consistent
with insulin resistance [32,33]. Total cholesterol levels, averaged 230.3 ± 32 mg/dL, reflecting the
typical increase in serum cholesterol seen in pregnancy [34]. The mean LDL peak diameter was 217.8 Å,
with 36% of the participants having a small, dense LDL phenotype B profile.
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Table 3. Participant Characteristics.
Characteristic Mean± SD or Percentage
Weeks of gestation 32.6 ± 1.8
Weight, kg 84.6 ± 15.2
Estimated Gestational Weight Gain, kg a 6.3 ± 4.7
Body Fat, % 41.9 ± 5.5
Blood Pressure
Systolic
Diastolic
104 ± 10.7
63 ± 5.9
Hemoglobin A1c, % 7.2 ± 0.6
Glucose, mg/dL 86.5 ± 7.4
Insulin, mU/L 13.9 ± 7.9
Triglycerides, mg/dL 214.4 ± 79.5
Leptin, ng/mL 3.60 ± 3.2
Ghrelin, pmol/L 14.1 ± 6.2
Adiponectin, ug/mL 7.3 ± 3.6
C-reactive protein, mg/dL 0.2 ± 0.1
Total cholesterol, mg/dL
High Density Lipoprotein-cholesterol, mg/dL
Low Density Lipoprotein-cholesterol, mg/dL
Very Low Density Lipoprotein-cholesterol, mg/dL
230.3 ± 32
74.2 ± 21.3
115.3 ± 34.3
40.8 ± 13.6
Low Density Lipoprotein Peak Diameter (Å) 217.8 ± 5
Apolipoprotein B, mg/dL 114 ± 24.6
Low Density Lipoprotein Phenotype (%)
A 52.8%
I 11.1%
B 36.1%
a Estimated Gestational Weight Gain at visit 1; an additional 1.3 ± 4 kg of weight was gained between visit 1 and
2 bringing the total to 7.7 ± 4.9 kg at 33 weeks gestation.
3.2. Metabolic Markers
The response of the metabolic biomarkers to the two test meals over time is shown in Figure 1.
None of the metabolites differed with the type of breakfast meal consumed at any of the postprandial
time points. Postprandial serum glucose, triglyceride, and ghrelin concentrations changed significantly
over the 5 h postprandial period. Serum glucose concentrations declined significantly during the 5 h
study period (p < 0.0001), while serum triglyceride and ghrelin concentrations significantly increased
(p = 0.002, p = 0.006). Insulin, c-peptide, apolipoprotein B and leptin concentrations did not change
significantly during the postprandial period.
3.3. Satiety Questionnaires and Buffet Lunch
VAS questionnaires were used to assess hunger following the two meals. The dairy meal satiety
response was slightly higher than that for nuts, but the difference was not significant. The satiety
response within a meal varied with time (p < 0.0001). Compared to the satiety status measured at 0.5 h,
the participants reported increased hunger and a lower satiety at 3 h postprandial. When the cream
cheese meal was consumed, the women felt that they could eat more than when they consumed the
almond meal (p < 0.01) at 3 and 4 h postprandial. However, the ad libitum caloric intake at the post-test
lunch meal did not significantly differ between the two test meals. Mean total energy consumption
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was 811 ± 288 kcal following the cream cheese test meal and 787 ± 260 kcal following the almond test
meal (p = 0.79).Nutrients 2019, 11, x FOR PEER REVIEW 
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Figure 1. Participant metabolic parameters after consumption of dairy vs. nut test meals.
4. Discussion
In this study of overweight/obese pregnant women, consuming cream cheese (dairy) or an
isocaloric and equal macronutrient amount of almonds (nuts) did not alter postprandial metabolism
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or subsequent meal intake amount. Since an energy equivalent amount of nuts provides more
unsaturated fat and fiber than cream cheese, we hypothesized that the postprandial metabolic glucose
and triglyceride response to almonds would be more favorable than the response to cream cheese.
Previous test-meal studies in non-pregnant adults have shown an improved postprandial glycemic
response when almonds were consumed [17,35]. However, those studies were not isocaloric and had
different amounts of fat as the metabolic effects of almonds were compared to white bread. In our
study, almond consumption did not shift the postprandial insulin, leptin, or ghrelin response, and,
consequently postprandial blood glucose and lipid levels did not change.
The amount of fiber was 4.5 times higher and the amount of saturated fat 6 times lower in the nut
meal compared to the dairy meal. Also, almonds contain higher amounts of certain micronutrients,
such as calcium, that have a role in energy metabolism and promoting fat oxidation [36]. Ideally,
postprandial studies of fat metabolism are longer than the 5 h used in this study because the metabolic
effects of the dietary fat may not be evident for 8 to 10 h [37]. Nevertheless, short-term studies show
that replacing saturated fatty acids with polyunsaturated fatty acids, such as those found in nuts,
decreases the serum triglyceride postprandial response and markers of inflammation [38]. In our study,
the postprandial serum triglyceride levels were unchanged at 5 h after both test meals.
The response to our satiety questions did not differ between the two test meals, with the exception
that more participants felt they could eat more at 3 and 4 h post consumption of the dairy meal
compared to the nut meal. Biomarkers of satiety, i.e., leptin and ghrelin, did not differ following each
test meal. We may have failed to see a satiety difference between our two meals because our study
was powered to detect differences in blood glucose rather than indicators of satiety or because the
macronutrient amounts were the same for both test meals.
Although the intake of nuts in our population of pregnant women did not alter metabolic
biomarkers compared to the intake of dairy, the addition of healthy fats and fiber (such as those
found in almonds) to the diets of high-risk obese pregnant women should be considered. Several
randomized, controlled, cross-over trials show that nuts may reduce cardiovascular disease risk
by altering inflammation, oxidation, glucoregulation, and circulating cholesterol [39–42]. Advising
overweight/obese women to consume unsaturated fatty acid-rich food items, prior to and during
pregnancy may enable them to enter pregnancy in a healthier state and to reduce their risk of metabolic
disorders during pregnancy.
5. Conclusions
In summary, our data show that consuming dairy or nuts in isocaloric test meals with equivalent
amounts of total fat, carbohydrate and protein had a minimal effect on postprandial metabolism as
measured by the response of glucose and lipid parameters as well as satiety and subsequent energy
intakes in overweight/obese pregnant women. The effect of pregnancy on the postprandial metabolic
response may be greater than the impact of the food items consumed.
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